The IRIS Phase 2 trial did not meet its primary endpoint in social communication deficits associated with ASDA prespecified analysis in ...

ASCO 2026 highlighted a shift toward precision-driven oncology R&D, where biomarkers, ctDNA, and integrated strategies guide ...

Over the past few decades, engineers have developed various devices that can create holograms, three-dimensional (3D) or ...

Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD U.S. patent to expire in March 2043, including 1,095 days ...

FutureG Office is investing in cutting-edge, next-gen techIt has handed $28m in funding to Cohere Technologies for the ...

Multi-Waveform Wireless Prototype Will Deliver Operational Aerial Surveillance and Response ISAC is a mission-first ...

Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPDU.S. patent to expire in March 2043, including 1,095 days of Patent Term AdjustmentNotice of allowance also recei ...

Because Krea relinquishes centralized control over the downstream deployment of its open weights, the contract legally binds ...

Researchers at Texas A&M University reported that two intranasal doses of extracellular vesicles derived from human neural ...

Learn the science behind why combining red light LEDs and infrared lasers is the most effective approach for deep-tissue recovery and reducing chronic inflammation.

The development of the 6G standard is entering a more concrete phase. At the June 2026 3GPP RAN Plenary in Singapore, the industry advanced several key areas under study and finalized the timeline for ...

SHANGHAI, CN / ACCESS Newswire / June 12, 2026 / The clinical datasets presented at ASCO 2026 further validate the trispecific synergistic mechanism of CS2009 and support its potential to become a ...